Diet Drug Acomplia Sales Disappoint; No Major Improvement Seen Until 2009
Sales of diet drug Acomplia (rimonabant) , available in Europe but not approved in the U.S., have turned into a major disappointment for Sanofi-Aventis, which says it does not expect the situation to significantly improve until new clinical trial results are ready for submission to regulators in [...]
Diet Pills: The Future
Diet Pills: The Future’
The quest for the perfect weight loss drug continues as the prevalence of obesity in the United States and other industrialized
countries rises.Why has it been so difficult for drug manufacturers to develop the “perfect” diet pill? One reason is that the causes of obesity are not [...]
Diet Pills and the FDA
Diet Pills and the FDA
Each year, millions of Americans resolve to lose weight—it is one of the most common New Year’s resolutions. Many people start off with great intentions, but within months, weeks, or even days, most of them give up and return to their usual habits. If they work to lose [...]
AMPHETAMINE-LIKE WEIGHT LOSS PRODUCTS
AMPHETAMINE-LIKE WEIGHT LOSS PRODUCTS
Amphetamines, which were introduced in 1938, rapidly became the most widely used agents for the treatment of obesity in the United States. Amphetamine (Figure ) is a stimulant that causes the release of the neurotransmitter norepinephrinein the brain, which leads to increased metabolism and increased energy expenditure, or burning of [...]
Diet Pill Acomplia Now Widely Available in Mexican Border Pharmacies
Diet drug Acomplia (rimonabant) , which seems at best months away from sale in the United States, is now widely available in pharmacies just across the Mexican border.
Readers increasingly are sending us reports on their experiences purchasing the highly anticipated diet pill in Mexican towns just across [...]
How Diet Pills Work
How Diet Pills Work
In the quest for the perfect diet pill, scientists, doctors, and those who are going to use these drugs need to understand how diet pills work. Knowing what actions a drug takes and how it affects the body helps scientists and doctors understand what side [...]
Global Sales of Acomplia (Rimonabant, Zimulti) Edge up to $50 Million in 2nd Quarter
Net sales of diet drug Acomplia (Rimonabant, Zimulti) edged up to almost $50 million (32 million Euros) in the second quarter of 2008, according to French pharmaceutical gians Sanofi-aventis.
This marked the strongest quarter for Acomplia (Rimonabant, Zimulti) since its launch two years ago, and was aided [...]
Europeans to Decide Whether to Further Restrict Diet Drug Acomplia This Week
Will diet drug Acomplia (rimonabant), taken this past year by more than 100,000 Europeans seeking to lose weight, be pulled from the European market out of concern over depressive and suicidal side-effects?
That decision will be made known July 19th following this week’s safety review by the European [...]
